This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
Notes to Financial Statements
Nature of Operations
Risks and Liquidity
Summary of Significant Accounting Policies
Pfizer License Agreement
Financing Liabilities
2027 Convertible Senior Notes
Fair Value Measurements
Financial Statement Components
Stockholders' Equity
Equity-Based Compensation
Net Loss Per Share
Income Taxes
Legal Proceedings
Commitments and Contingencies
Related Parties
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Financing Liabilities (Tables)
2027 Convertible Senior Notes (Tables)
Fair Value Measurements (Tables)
Financial Statement Components (Tables)
Equity-Based Compensation (Tables)
Net Loss Per Share (Tables)
Notes Details
Pfizer License Agreement - Additional Information (Details)
Financing Liabilities - Additional Information (Details)
Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)
2027 Convertible Senior Notes - Additional Information (Details)
2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)
2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)
2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)
Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)
Fair Value Measurements - Additional Information (Details)
Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)
Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)
Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)
Financial Statement Components - Summary of Property and Equipment Net (Details)
Financial Statement Components - Summary of Other Long-Term Assets (Details)
Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)
Financial Statement Components - Summary of Interest Income (Expense), Net (Details)
Financial Statement Components - Summary of Other Income (Expense), Net (Details)
Stockholders' Equity, Preferred Stock and Common Stock (Details)
Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)
Equity-Based Compensation - Summary of Stock Options Activity (Details)
Equity-Based Compensation - Additional Information (Details)
Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)
Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)
Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)
Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)
Income Taxes - Additional Information (Details)
Commitments and Contingencies - Additional Information (Details)
Related Parties (Details)
Subsequent Events - Additional Information (Details)
All Reports